CNS Pharma Says FDA Oks Protocol Amendment To PPivotal Global Trial Of Berubicin For GBM

RTTNews | 1063 days ago
CNS Pharma Says FDA Oks Protocol Amendment To PPivotal Global Trial Of Berubicin For GBM

(RTTNews) - Biopharmaceutical company CNS Pharmaceuticals, Inc. (CNSP) announced Thursday that it has received approval from the U.S. Food and Drug Administration (FDA) for its ongoing potentially pivotal global study evaluating the efficacy and safety of Berubicin compared with Lomustine (Gleostine) administered after first line therapy for the treatment of recurrent glioblastoma multiforme (GBM), one of the most aggressive types of brain cancer.

Berubicin is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier currently being evaluated in a global potentially pivotal study evaluating its efficacy and safety.

The potentially pivotal trial is an adaptive, multicenter, open-label, randomized and controlled study in adult patients with recurrent glioblastoma multiforme (WHO Grade IV) after failure of standard first-line therapy. The primary endpoint of the study is Overall Survival (OS).

Results from the trial will compare Berubicin to a current standard of care (Lomustine), with a 2 to 1 randomization of patients to receive either Berubicin or Lomustine.

The amended protocol expands eligibility for the study to patients who have received additional treatments as part of the first line therapy for their disease considering advancements in this area.

A pre-planned, non-binding futility analysis will be performed after 30 to 50% of all planned patients have completed 6 months on therapy. This evaluation will include safety as well as secondary efficacy endpoints.

The FDA has granted CNS Pharmaceuticals Fast Track Designation and Orphan Drug Designation for Berubicin.

read more
Swiss Markets Ends Modestly Lower

Swiss Markets Ends Modestly Lower

The Switzerland market ended lower on Wednesday after languishing in negative territory right through the day's trading session, as concerns about trade and geopolitical uncertainty rendered the mood cautious, prompting investors to refrain from making significant moves.
RTTNews | 42 minutes ago
European Stocks Close On Mixed Note Amid Geopolitical, Trade Uncertainty

European Stocks Close On Mixed Note Amid Geopolitical, Trade Uncertainty

European stocks turned in a mixed performance on Wednesday after a cautious session as investors awaited clarity on the trade front. The impasse in Ukraine peace talks and data showing a bigger than expected increase in UK inflation weighed on sentiment. A downward revision in U.S. federal deficit weighed as well.
RTTNews | 1h 19min ago
Bay Street Seen Opening On Mixed Note

Bay Street Seen Opening On Mixed Note

Canadian shares are likely to open on a mixed note Wednesday morning. Weak European stocks, concerns about U.S. debt, impasse over peace talks and a lack of progress in trade negotiations may weigh on sentiment. Firm bullion and crude oil prices could trigger buying in resources sectors and limit market's downside.
RTTNews | 5h 59min ago
UK Inflation Strongest Since Early 2024 On Household Bills, Employer Tax

UK Inflation Strongest Since Early 2024 On Household Bills, Employer Tax

UK consumer price inflation accelerated sharply to the highest level in more than a year in April due to higher domestic bills and the hike in employers' taxes, official data revealed on Wednesday. The consumer price index rose by a bigger-than-expected 3.5 percent year-on-year in April, which was faster than the 2.6 percent increase in March, the Office for National Statistics reported.
RTTNews | 6h 50min ago
FTSE 100 Down Marginally As Investors Focus On Inflation Data, Earnings

FTSE 100 Down Marginally As Investors Focus On Inflation Data, Earnings

U.K. stocks are marginally down on Wednesday amid concerns over an impasse in Russia-Ukraine peace talks, a lack of progress in trade negotiations, and data showing an acceleration in British consumer price inflation in the month of April. Investors are also reacting to some corporate earnings announcements.
RTTNews | 6h 57min ago
CAC 40 Moderately Lower In Cautious Trade

CAC 40 Moderately Lower In Cautious Trade

French stocks are under a bit of pressure on Wednesday amid uncertainty about Ukraine-Russia peace talks, and a lack of positive progress on the trade front. The recent downgrade of U.S. sovereign credit rating by Moody's weigh as well on investor sentiment.
RTTNews | 7h 30min ago
Sensex, Nifty Snap Three-day Losing Streak

Sensex, Nifty Snap Three-day Losing Streak

Indian shares eked out modest gains on Wednesday, after having suffered heavy losses in the previous session amid rising geopolitical tensions, growing concerns over U.S. debt and a spike in Covid-19 cases in Southeast Asia.
RTTNews | 7h 37min ago
DAX Drifts Lower On Geopolitical Concerns

DAX Drifts Lower On Geopolitical Concerns

German stocks are down in negative territory on Wednesday as investors make cautious moves, awaiting fresh news on the trade front. The impasse in Ukraine peace talks and data showing a bigger than expected increase in UK inflation weigh on sentiment.
RTTNews | 7h 58min ago